Cargando…

Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery

OBJECTIVE: To compare intravenous (IV) amoxicillin/clavulanic acid (A/CA) to IV cefuroxime plus metronidazole (C + M) for preventing surgical site infections (SSI) in colorectal surgery. BACKGROUND: Given their spectra that include most Enterobacterales and anaerobes, C + M is commonly recommended a...

Descripción completa

Detalles Bibliográficos
Autores principales: Stavropoulou, Elisavet, Atkinson, Andrew, Eisenring, Marie-Christine, Fux, Christoph A., Marschall, Jonas, Senn, Laurence, Troillet, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510121/
https://www.ncbi.nlm.nih.gov/pubmed/37726838
http://dx.doi.org/10.1186/s13756-023-01307-y
_version_ 1785107897116524544
author Stavropoulou, Elisavet
Atkinson, Andrew
Eisenring, Marie-Christine
Fux, Christoph A.
Marschall, Jonas
Senn, Laurence
Troillet, Nicolas
author_facet Stavropoulou, Elisavet
Atkinson, Andrew
Eisenring, Marie-Christine
Fux, Christoph A.
Marschall, Jonas
Senn, Laurence
Troillet, Nicolas
author_sort Stavropoulou, Elisavet
collection PubMed
description OBJECTIVE: To compare intravenous (IV) amoxicillin/clavulanic acid (A/CA) to IV cefuroxime plus metronidazole (C + M) for preventing surgical site infections (SSI) in colorectal surgery. BACKGROUND: Given their spectra that include most Enterobacterales and anaerobes, C + M is commonly recommended as prophylaxis of SSI in colorectal surgery. A/CA offers good coverage of Enterobacterales and anaerobes as well, but, in contrast to C + M, it also includes Enterococcus faecalis which is also isolated from patients with SSI and could trigger anastomotic leakage. METHODS: Data from a Swiss SSI surveillance program were used to compare SSI rates after class II (clean contaminated) colorectal surgery between patients who received C + M and those who received A/CA. We employed multivariable logistic regression to adjust for potential confounders, along with propensity score matching to adjust for group imbalance. RESULTS: From 2009 to 2018, 27,922 patients from 127 hospitals were included. SSI was diagnosed in 3132 (11.2%): 278/1835 (15.1%) in those who received A/CA and 2854/26,087 (10.9%) in those who received C + M (p < 0.001). The crude OR for SSI in the A/CA group as compared to C + M was 1.45 [CI 95% 1.21–1.75]. The adjusted OR was 1.49 [1.24–1.78]. This finding persisted in a 1:1 propensity score matched cohort of 1835 patients pairs with an OR of 1.60 [1.28–2.00]. Other factors independently associated with SSI were an ASA score > 2, a longer duration of operation, and a reoperation for a non-infectious complication. Protective factors were female sex, older age, antibiotic prophylaxis received 60 to 30 min before surgery, elective operation, and endoscopic approach. CONCLUSIONS: Despite its activity against enterococci, A/CA was less effective than C + M for preventing SSI, suggesting that it should not be a first choice antibiotic prophylaxis for colorectal surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-023-01307-y.
format Online
Article
Text
id pubmed-10510121
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105101212023-09-21 Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery Stavropoulou, Elisavet Atkinson, Andrew Eisenring, Marie-Christine Fux, Christoph A. Marschall, Jonas Senn, Laurence Troillet, Nicolas Antimicrob Resist Infect Control Research OBJECTIVE: To compare intravenous (IV) amoxicillin/clavulanic acid (A/CA) to IV cefuroxime plus metronidazole (C + M) for preventing surgical site infections (SSI) in colorectal surgery. BACKGROUND: Given their spectra that include most Enterobacterales and anaerobes, C + M is commonly recommended as prophylaxis of SSI in colorectal surgery. A/CA offers good coverage of Enterobacterales and anaerobes as well, but, in contrast to C + M, it also includes Enterococcus faecalis which is also isolated from patients with SSI and could trigger anastomotic leakage. METHODS: Data from a Swiss SSI surveillance program were used to compare SSI rates after class II (clean contaminated) colorectal surgery between patients who received C + M and those who received A/CA. We employed multivariable logistic regression to adjust for potential confounders, along with propensity score matching to adjust for group imbalance. RESULTS: From 2009 to 2018, 27,922 patients from 127 hospitals were included. SSI was diagnosed in 3132 (11.2%): 278/1835 (15.1%) in those who received A/CA and 2854/26,087 (10.9%) in those who received C + M (p < 0.001). The crude OR for SSI in the A/CA group as compared to C + M was 1.45 [CI 95% 1.21–1.75]. The adjusted OR was 1.49 [1.24–1.78]. This finding persisted in a 1:1 propensity score matched cohort of 1835 patients pairs with an OR of 1.60 [1.28–2.00]. Other factors independently associated with SSI were an ASA score > 2, a longer duration of operation, and a reoperation for a non-infectious complication. Protective factors were female sex, older age, antibiotic prophylaxis received 60 to 30 min before surgery, elective operation, and endoscopic approach. CONCLUSIONS: Despite its activity against enterococci, A/CA was less effective than C + M for preventing SSI, suggesting that it should not be a first choice antibiotic prophylaxis for colorectal surgery. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13756-023-01307-y. BioMed Central 2023-09-19 /pmc/articles/PMC10510121/ /pubmed/37726838 http://dx.doi.org/10.1186/s13756-023-01307-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Stavropoulou, Elisavet
Atkinson, Andrew
Eisenring, Marie-Christine
Fux, Christoph A.
Marschall, Jonas
Senn, Laurence
Troillet, Nicolas
Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery
title Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery
title_full Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery
title_fullStr Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery
title_full_unstemmed Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery
title_short Association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery
title_sort association of antimicrobial perioperative prophylaxis with cefuroxime plus metronidazole or amoxicillin/clavulanic acid and surgical site infections in colorectal surgery
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510121/
https://www.ncbi.nlm.nih.gov/pubmed/37726838
http://dx.doi.org/10.1186/s13756-023-01307-y
work_keys_str_mv AT stavropoulouelisavet associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery
AT atkinsonandrew associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery
AT eisenringmariechristine associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery
AT fuxchristopha associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery
AT marschalljonas associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery
AT sennlaurence associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery
AT troilletnicolas associationofantimicrobialperioperativeprophylaxiswithcefuroximeplusmetronidazoleoramoxicillinclavulanicacidandsurgicalsiteinfectionsincolorectalsurgery